DAVID W J MCGIRR
CIK 1219023 · SVP & Chief Financial Officer · last filed 2026-02-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.20M
Companies
9
Total Filings
75
Lifetime Open-Market Net
-$10.94M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INSM | Director | 97,723 | $97.85 | $9.56M | -$451.5K | 16 | 2026-02-11 |
| RYTM | Director | 7,000 | $88.38 | $618.7K | -$4.27M | 11 | 2025-06-26 |
| XFOR | Director | 4,722 | $4.00 | $18.9K | $0 | 7 | 2025-06-10 |
| VYNE Therapeutics Inc. (MNLO) Delisted | Director | — | — | — | $0 | 2 | 2019-08-08 |
| ASNS | Director | — | $0.08 | — | $0 | 3 | 2018-06-07 |
| Roka BioScience, Inc. (ROKA) Delisted | Director | 50,000 | — | — | $180.1K | 4 | 2017-06-30 |
| Relypsa Inc (RLYP) Delisted | Director | 2,250 | — | — | -$61.9K | 5 | 2016-09-02 |
| CUBIST PHARMACEUTICALS INC (CBST) Delisted | SVP & Chief Financial Officer | 23,980 | — | — | -$6.34M | 26 | 2013-02-20 |
| LIFECELL CORP (VITA) Delisted | Director | — | — | — | $0 | 1 | 2008-06-04 |
Recent Filings · Page 5 of 8
75 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-06-26 | Roka BioScience, Inc. (ROKA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-15 | Relypsa Inc (RLYP) Delisted | Sell (S) | −1,220 | -$42.3K | EDGAR |
| 2015-06-09 | Relypsa Inc (RLYP) Delisted | Grant (A) | +2,250 | $0 | EDGAR |
| 2015-01-09 | INSM | Grant (A) | +6,222 | $0 | EDGAR |
| 2014-11-17 | Roka BioScience, Inc. (ROKA) Delisted | Buy (P) | +50,000 | $180.1K | EDGAR |
| 2014-11-04 | INSM | Exer (M) | +702 | $0 | EDGAR |
| 2014-01-14 | INSM | Grant (A) | +2,928 | $0 | EDGAR |
| 2013-11-01 | INSM | Grant (A) | — | $0 | EDGAR |
| 2013-02-20 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Mixed | +1,500 | $0 | EDGAR |
| 2012-09-24 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Mixed | — | -$591.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.